CervoMed Inc.

Pharmaceutical company · Boston, Massachusetts, United States · Nasdaq: CRVO

CervoMed Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker CRVO. It has reported private securities offerings to the US SEC, most recently $750,001 sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

CervoMed at a glance

Typepharmaceutical company
HeadquartersBoston, Massachusetts, United States
Earliest incorporation on record2015
Stock listingNasdaq: CRVO
SEC industryPharmaceutical Preparations
SEC CIK1171623, 1053691

What does CervoMed do?

Private fundraising reported to the SEC

14 Form D notices; the most recent reported $750,001 sold (2020).

Frequently asked questions about CervoMed

Where is CervoMed headquartered?

CervoMed Inc. is headquartered in Boston, Massachusetts, United States.

What does CervoMed do?

CervoMed Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is CervoMed a public company?

Yes. CervoMed Inc. trades on Nasdaq under the ticker CRVO.

When was CervoMed founded?

The earliest incorporation on record for CervoMed Inc. is in 2015, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences